The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Kotova O.V.

otdel patologii vegetativnoĭ nervnoĭ sistemy NITs Moskovskoĭ meditsinskoĭ akademii im. I.M. Sechenova

Akarachkova E.S.

Otdel patologii vegetativnoĭ nervnoĭ sistemy nauchno-issledovatel'skogo tsentra Pervogo MGMU im. I.M. Sechenova

Diabetic autonomic polyneuropathy

Authors:

Kotova O.V., Akarachkova E.S.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(2): 169‑173

DOI: 10.17116/jnevro201711721169-173

Read: 9339 times

Contact the author
Table of contents

DIABETIC AUTONOMIC POLYNEUROPATHY
DIABETIC AUTONOMIC POLYNEUROPATHY

To cite this article:

Kotova OV, Akarachkova ES. Diabetic autonomic polyneuropathy. S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(2):169‑173. (In Russ.)
https://doi.org/10.17116/jnevro201711721169-173

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Abstract:

Currently, about 415 million of the adult population suffer from diabetes mellitus (DM), and the number of CD patients is expected to increase to 642 million in 2040. Neuropathy is the most prevalent complication of CD, it affected 60% of patients. Diabetic autonomic polyneuropathy (DAP), a type of diabetic peripheral polyneuropathy, is frequently associated with disease duration and poor glycaemia control. DAP can affect either all organs and systems or only some of them (e.g., cardiovascular system, gastrointestinal tract, urogenital system). Cardiac autonomic neuropathy (CAN) is associated with the increase in cardiovascular morbidity and mortality. Orthostatic hypotension, a main symptom of CAN, is an independent risk factor of myocardial infarction, stroke, heart failure, arrhythmia. Treatment of DAP should be directed to both metabolic and vascular disturbances. To reach and maintain normal blood glucose level is the main goal in the prevention and impeding diabetic neuropathy. Thiamine-containing compounds, including neurobion in tablet or injection forms, can be recommended to patients with diabetic polyneuropathy as well.

Keywords:

diabetic autonomic polyneuropathy
cardiac autonomic neuropathy
thiamine
pyridoxine
cyanocobalamin

Authors:

Kotova O.V.

otdel patologii vegetativnoĭ nervnoĭ sistemy NITs Moskovskoĭ meditsinskoĭ akademii im. I.M. Sechenova

Akarachkova E.S.

Otdel patologii vegetativnoĭ nervnoĭ sistemy nauchno-issledovatel'skogo tsentra Pervogo MGMU im. I.M. Sechenova

Close metadata

References:

  1. Timar B, Timar R, Gaiță L, Oancea C, Levai C, Lungeanu D. The Impact of Diabetic Neuropathy on Balance and on the Risk of Falls in Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Study. PLoS One. 2016;27;11(4):0154654. doi:10.1371/journal.pone.0154654
  2. Lagani V, Koumakis L, Chiarugi F, Lakasing E, Tsamardinos I. A systematic review of predictive risk models for diabetes complications based on large scale clinical studies. J Diabetes Complications. 2013;27(4):407-413. doi:10.1016/j.jdiacomp.2012.11.003
  3. Dyck PJ, Kratz KM, Karnes JL, Litchy WJ, Klein R, Pach JM, Wilson DM, O'Brien PC, Melton LJ. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology. 1993;43(4):817-824. doi:10.1212/wnl.43.4.817
  4. Low PA, Vernino S, Suarez G. Autonomic dysfunction in peripheral nerve disease. Muscle Nerve. 2003;27:646-661. doi:10.1002/mus.10333
  5. Vinik AI, Casellini C, Névoret ML. Alternative Quantitative Tools in the Assessment of Diabetic Peripheral and Autonomic Neuropathy. International Review of Neurobiology. 2016;127:235-285. doi:10.1016/bs.irn.2016.03.010
  6. Vinik AI, Erbas T. Recognizing and treating diabetic autonomic neuropathy. Cleveland Clinic Journal of Medicine. 2001;68:928-930. doi:10.3949/ccjm.68.11.928
  7. Vinik AI, Ziegler D. Diabetic cardiovascular autonomic neuropathy. Circulation. 2007;115:387-397. doi:10.1161/circulationaha.106.634949
  8. Duchen LW, Anjorin A, Watkins PJ, Mackay JD. Pathology of autonomic neuropathy in diabetes mellitus. Annals of Internal Medicine. 1980;92:301-303. doi:10.7326/0003-4819-92-2-301
  9. Tahrani AA, Dubb K, Raymond NT, Begum S, Altaf QA, Sadigi H, Piya MK, Stevens MJ. Cardiac autonomic neuropathy predicts renal function decline in patients with type 2 diabetes: a cohort study. Diabetologia. 2014;57(6):1249-1256. doi:10.1007/s00125-014-3211-2
  10. Raman R, Gupta A, Krishna S, Kulothungan V, Sharma T. Prevalence and risk factors for diabetic microvascular complications in newly diagnosed type II diabetes mellitus. Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetic Study (SN-DREAMS, report 27). J Diabetes Complications. 2012;26(2):123-128. doi:10.1016/j.jdiacomp.2012.02.001
  11. Dimitropoulos G, Tahrani AA, Stevens MJ. Cardiac autonomic neuropathy in patients with diabetes mellitus. World J Diabetes. 2014;5(1):17-39. doi:10.4239/wjd.v5.i1.17
  12. Shibao C, Grijalva CG, Raj SR, Biaggioni I, Griffin MR. Orthostatic hypotension-related hospitalizations in the United Sates. The American Journal of Medicine. 2007;120(11):975-980. doi:10.1016/j.amjmed.2007.05.009
  13. Ricci F, De Caterina R, Fedorowski A. Orthostatic Hypotension: Epidemiology, Prognosis, and Treatment. Journal of the American College of Cardiology. 2015;18;66(7):848-860. doi:10.1016/j.jacc.2015.06.1084
  14. Veronese N, De Rui M, Bolzetta F, Zambon S, Corti MC, Baggio G, Toffanello ED, Maggi S, Crepaldi G, Perissinotto E, Manzato E, Sergi G. Orthostatic changes in blood pressure and mortality in the elderly: the Pro.V.A Study. American Journal of Hypertension. 2015;28(10):1248-1256. doi:10.1093/ajh/hpv022
  15. Lacigova S, Brozova J, Cechurova D, Tomesova J, Krcma M, Rusavy Z. The influence of cardiovascular autonomic neuropathy on mortality in type 1 diabetic patients; 10-year follow-up. Biomedical Papers. 2016;160(1):111-117. doi:10.5507/bp.2015.063
  16. Ewing DJ, Martyn CN, Young RJ, Clarke BF. The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care. 1985;8:491-498. doi:10.2337/diacare.8.5.491
  17. Thornalley P, Babaei-Jadidi R, Al Ali, Rabbani N, Antonysunil A, Larkin J, Ahmed A, Rayman G, Bodmer CW. High prevalence of low plasma thiamine concentration in diabetes linked to a marker of vascular disease. Diabetologia. 2007:50(10):2164-2170. doi:10.1007/s00125-007-0771-4
  18. Kotova OV. Diabetic neuropathy. The use of neurotropic vitamins. Poliklinika. 2015;1(2):36-39. (In Russ.).
  19. Cameron N, Gibson T, Nangle M. Inhibitors of advanced glycation end product formation and neurovascular dysfunction in experimental diabetes. Annals of the New York Academy of Sciences. 2005;1043:784-792. doi:10.1196/annals.1333.091
  20. Nikolic A, Kacar A, Lavrnic D. The effect of benfothiamine in the therapy of diabetic polyneuropathy. Srpski arhiv za celokupno lekarstvo. 2009;137(11-12):594-600. doi:10.2298/sarh0912594n
  21. Satyanarayana A, Balakrishna N, Pitla S, Reddy PY, Mudili S, Lopamudra P, Suryanarayana P, Viswanath K, Ayyagari R, Reddy GB. Status of B-vitamins and homocysteine in diabetic retinopathy: association with vitamin-B12 deficiency and hyperhomocysteinemia. PLoS One. 2011;6(11):26747. doi:10.1371/journal.pone.0026747
  22. Obeid R, Jung J, Falk J, Herrmann W, Geisel J, Friesenhahn, Friesenhahn-Ochs B, Lammert F, Fassbender K, Kostopoulos P. Serum vitamin B12 not reflecting vitamin B12 status in patients with type 2 diabetes. Biochimie. 2013;95(5):1056-1061. doi:10.1016/j.biochi.2012.10.028
  23. Ben Ahmed H, Bouzid K, Hassine M, Saadi O, Bahlous A, Abdelmoula J, Baccar H, Ben Mami Ben Miled F. Prevalence of non-conventional cardiovascular risk factors in Tunisian diabetics. La Presse Médicale. 2014;43(1):9-16. doi:10.1016/j.lpm.2013.07.019
  24. Molina M, GonzA lez R, Folgado J, Real J.T, MartA-nez-HervA s S, Priego A, Lorente R, Chaves F.J, Ascaso J.F. Correlation between plasma concentrations of homocysteine and diabetic polyneuropathy evaluated with the Semmes-Weinstein monofilament test in patients with type 2 diabetes mellitus. Medicina Clínica. 2013;141(9):382-386. doi:10.1016/j.medcli.2012.09.042
  25. Li J, Shi M, Zhang H, Yan L, Xie M, Zhuang L, Zhu Y, Chen J. Relation of homocysteine to early nephropathy in patients with Type 2 diabetes. Clinical Nephrology. 2012;77(4):305-310. doi:10.5414/CN107296
  26. Ho M, Halim JH, Gow ML, El-Haddad N, Marzulli T, Baur LA, Cowell CT, Garnett SP. Vitamin B12 in obese adolescents with clinical features of insulin resistance. Nutrients. 2014;4:6(12):5611-568. doi:10.3390/nu6125611
  27. Xu Q, Pan J, Yu J, Liu X, Liu L, Zuo X, Wu P, Deng H, Zhang J, Ji A. Meta-analysis of methylcobalamin alone and in combination with lipoic acid in patients with diabetic peripheral neuropathy. Diabetes Research and Clinical Practice. 2013;101(2):99-105. doi:10.1016/j.diabres.2013.03.033
  28. Ahn HJ, Min KW, Cho YO. Assessment of vitamin B(6) status in Korean patients with newly diagnosed type 2 diabetes. Nutrition Research and Practice. 2011;5(1):34-39. doi:10.4162/nrp.2011.5.1.34
  29. Kotova OV. Diabetic autonomic polyneuropathy. Farmateka. 2012;6:40-44. (In Russ.).
  30. Stracke H, Gaus W, Achenbach U, Federlin K, Bretzel R. Benfotiamine in Diabetic Polyneuropathy (BENDIP): Results of a randomized, double-blind, placebo-controlled clinical study. Experimental and Clinical Endocrinology & Diabetes. 2008;16:600-605. doi:10.1055/s-2008-1065351
  31. Janka H, Rietzel S, Mehnert H. The influence of Neurobion on temperature sensibility in patients with diabetic polyneuropathy. Results of a placebo-controlled pilot study. Pharmakologie und klinische Anwendung hochdosierter B-Vitamine. 1991;87-97. doi:10.1007/978-3-642-85410-1_9
  32. Kamchatnov PR, Umarova HYa, Chugunov AV. Application neyrobion drug in neurological practice. Zhurnal nevrologii i psihiatrii im. S.S. Korsakova. 2015;9:60-64. doi:10.17116/jnevro20151159160-64
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.